TAVR

IRVINE, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc. (“JenaValve or the “Company”), developer and manufacturer of differentiated transcatheter aortic valve replacement (TAVR) systems, today announced that it has…

New York, United States, June 21, 2022 (GLOBE NEWSWIRE) -- The main thing driving the aortic valve replacement market is the growing number of valvular diseases like aortic stenosis and aortic regurgitation, as well as technological…

Researchers keeping an eye on the long-term outcomes of people undergoing transcatheter aortic valve replacement (TAVR) reported encouraging results in both clinical and economic…

People with bicuspid aortic stenosis and low surgical risk did not appear to be at a disadvantage for short-term outcomes after transcatheter…

German recipients of the AstraZeneca COVID-19 vaccine showed that severe headache can precede cerebral venous sinus thrombosis by a few days in…

A direct oral anticoagulant (DOAC) passed a test of efficacy but tripped up over bleeding rates when used for patients who came out of successful transcatheter aortic valve…

Nagpur: The Transcatheter aortic valve replacement or TAVR is a skilled procedure to replace the valve in heart while avoiding the open heart surgery. Such surgeries are performed in Nagpur often in last five years, as the city has emerged…

The TriGuard 3 cerebral protection device received no shining endorsement for approval from FDA advisors, who instead highlighted all the ways…

A case report described carotid arterial thrombosis discovered in a 31-year-old man following his first dose of the AstraZeneca adenovirus vector…

Compared with redo surgery for a failed aortic bioprosthesis, valve-in-valve transcatheter aortic valve replacement (TAVR) offered some clinical advantages in the hospital at the…